Dengu Fungai, Azhar Bilal, Patel Shaneel, Hakim Nadey
London Postgraduate School of Surgery, London, UK.
Exp Clin Transplant. 2015 Jun;13(3):209-13.
Autosomal dominant polycystic disease is a multisystem inherited condition affecting the kidneys and is an important cause of end-stage renal disease. Patients with autosomal dominant polycystic disease experience symptoms related to size and cystic nature of their kidneys, which can be difficult to manage. Traditionally, the only surgical option for management was open bilateral/unilateral native nephrectomy, which carried with it significant morbidity and mortality. Therefore, it was deemed unsafe and rarely performed. However, surgery for autosomal dominant polycystic disease has evolved rapidly with the advent of minimally invasive surgery and improved medical management of end-stage renal failure patients. Laparoscopic and hand-assisted laparoscopic techniques have been adopted and have demonstrated reduced morbidity. The timing of this intervention in relation to transplant is controversial and presents a major challenge in managing this patient population.
常染色体显性多囊肾病是一种影响肾脏的多系统遗传性疾病,是终末期肾病的重要病因。常染色体显性多囊肾病患者会出现与肾脏大小和囊肿性质相关的症状,这些症状可能难以处理。传统上,唯一的手术治疗选择是开放性双侧/单侧自体肾切除术,该手术伴有较高的发病率和死亡率。因此,该手术被认为不安全且很少实施。然而,随着微创手术的出现以及终末期肾衰竭患者医疗管理的改善,常染色体显性多囊肾病的手术治疗发展迅速。腹腔镜和手辅助腹腔镜技术已被采用,并已证明发病率有所降低。这种干预相对于移植的时机存在争议,并且在管理这一患者群体方面构成了重大挑战。